Laiba Husain | AI in Healthcare | Best Researcher Award

Dr. Laiba Husain | AI in Healthcare | Best Researcher Award

Early Impact Scholar at University of Texas Southwestern Medical Center | United States

Dr. Laiba Husain is a distinguished public health researcher specializing in translational health sciences and primary care. Her academic journey reflects an exceptional commitment to advancing healthcare equity, particularly in digital health and marginalized communities. Currently serving as an Early Impact Scholar at the Peter O’Donnell School of Public Health, UT Southwestern Medical Center, she integrates multidisciplinary approaches to address pressing healthcare challenges. Her expertise spans qualitative and mixed-methods research, stakeholder engagement, and health policy development. Through impactful collaborations across leading institutions, Dr. Husain has contributed to groundbreaking studies that influence both clinical practice and healthcare delivery worldwide.

Profile:

Scopus | Orcid

Education:

Dr. Husain’s academic foundation began with a Bachelor of Science in Biopsychology, Cognition, and Neuroscience from the University of Michigan , where she was recognized as a James B. Angell Scholar. As a Fulbright Scholar, she earned her Master of Public Health from the University of Birmingham, gaining international perspectives on health systems. she completed her Doctor of Philosophy in Translational Health Sciences at the University of Oxford under Dr. Trish Greenhalgh’s supervision. Her doctoral work focused on health disparities in digital care delivery, merging rigorous methodology with real-world application to inform evidence-based interventions.

Experience:

Dr. Husain’s career includes progressive roles at globally renowned institutions. she was a Research Associate at the University of Oxford, contributing to EU-wide healthcare initiatives.  she worked as a Research Analyst in the Nuffield Department of Primary Care Health Sciences, enhancing methodological rigor across diverse projects. Concurrently, she served as a consultant with The Healthcare Improvement Studies Institute at the University of Cambridge, advising on healthcare improvement strategies. she has advanced public health research at UT Southwestern, with a focus on tele-oncology and regional healthcare partnerships.

Research Interests:

Dr. Husain’s research interests converge on healthcare equity, digital health disparities, and patient-centered care. She investigates how intersecting disadvantages such as socioeconomic status, language barriers, and age affect access to digital healthcare solutions. Her work employs qualitative and mixed-methods approaches to capture nuanced patient experiences and inform inclusive policy frameworks. She is particularly engaged in developing practical tools, such as user personas, to address barriers in digital consultations for marginalized populations. Additionally, her studies explore the integration of telehealth in primary care and public health, aiming to improve system responsiveness, accessibility, and cultural competence in healthcare delivery.

Awards and Honors:

Dr. Husain’s contributions have been recognized through numerous honors. These include the James B. Angell Scholar Award  for academic excellence, the prestigious Fulbright Scholar Award and the Dean’s University Scholar Award from Oxford . She received a Doctoral Fellowship Award from The Health Improvements Studies Institute  and  honored in the International Women of Impact Portrait Series at Green Templeton College. Most recently, she earned the Nuffield Departmental Award for Outstanding Doctoral Dissertation, highlighting her innovative contributions to translational health sciences and the field’s understanding of digital health disparities.

Publications:

Title: Management of post-acute covid-19 in primary care

Citation: 102

year of Publications: 2020

Title:  Long Covid – the illness narratives

Citation: 65

year of Publications: 2021

Title: I can’t cope with multiple inputs a qualitative study of the lived experience of brain fog after COVID-19

Citation: 45

year of Publications: 2022

Title: Desperately seeking intersectionality in digital health disparity research: narrative review to inform a richer theorization of multiple disadvantage

Citation: 30

year of Publications: 2022

Title: Safety implications of remote assessments for suspected COVID-19 qualitative study in UK primary care

Citation: 20

year of Publications: 2023

Title: Developing user personas to capture intersecting dimensions of disadvantage in older patients who are marginalised: a qualitative studyprimary care

Citation: 12

year of Publications: 2024

Title: Examining Intersectionality and Barriers to the Uptake of Video Consultations Among Older Adults From Disadvantaged Backgrounds With Limited English Proficiency: Qualitative Narrative Interview Study

Citation: 1

year of Publications: 2025

Conclusion:

Dr. Laiba Husain exemplifies the synthesis of academic excellence, research innovation, and real-world healthcare impact. Her interdisciplinary approach bridges gaps between patient experiences, digital health innovation, and public health policy. By fostering collaborations among clinicians, policymakers, and community stakeholders, she has advanced evidence-based solutions addressing complex health inequalities. Her scholarly work not only deepens theoretical understanding but also delivers tangible benefits to underserved populations. With a trajectory marked by high-impact research, leadership in healthcare initiatives, and dedication to mentorship, Dr. Husain stands as an influential figure driving the future of equitable and effective healthcare delivery.

Gang Wang | AI in Healthcare | Best Researcher Award

Prof. Dr. Gang Wang | AI in Healthcare | Best Researcher Award

Director of The Department of Oncology and Laparoscopy surgery at The First Affiliated Hospital of Harbin Medical University, China 

Dr. Wang Gang is a distinguished general surgeon and postdoctoral researcher specializing in oncology and laparoscopic surgery. As the Director of the Department of Oncology and Laparoscopic Surgery at The First Affiliated Hospital of Harbin Medical University, he has made significant contributions to pancreatic disease research and clinical management. Recognized as a High-Level Talent of Heilongjiang Province, Dr. Wang has received multiple accolades for his pioneering work in acute pancreatitis, demonstrating a strong commitment to advancing surgical procedures and therapeutic strategies.

Profile

Scholar

Education

Dr. Wang earned his medical degree (MD) and doctoral degree (Ph.D.) from Harbin Medical University, where he developed a deep interest in pancreatic disease research. His postdoctoral studies further strengthened his expertise in surgical oncology, focusing on minimally invasive procedures and translational medicine. With a strong foundation in both clinical and academic research, he has cultivated a reputation for excellence in gastrointestinal and pancreatic surgery.

Experience

With years of clinical practice and research experience, Dr. Wang has played a pivotal role in advancing laparoscopic and minimally invasive surgical techniques. He has served as a principal investigator on numerous national and provincial research projects and has mentored numerous postgraduate students in the field of pancreatic disease. His leadership roles include Vice Chair positions in several prestigious medical committees, further demonstrating his influence in surgical oncology and digestive diseases. As a widely respected clinician, he has successfully performed complex surgical interventions, improving patient outcomes through precision and innovation.

Research Interests

Dr. Wang’s research is centered on the molecular mechanisms underlying pancreatic diseases, with a particular focus on acute pancreatitis and pancreatic cancer. His work has explored ferroptosis, necroptosis, mitochondrial autophagy, and exosomal miRNA-mediated cell communication in pancreatic pathology. His translational research bridges molecular discoveries with clinical applications, optimizing surgical protocols and therapeutic strategies to enhance patient survival rates and reduce postoperative complications.

Awards

Dr. Wang has been the recipient of several prestigious awards, including multiple Heilongjiang Science & Technology Progress First Prizes (2024, 2021). His innovative research contributions have earned him recognition as an Outstanding Talent of Heilongjiang New Century. He has been honored with more than 14 provincial and national awards, acknowledging his significant impact on pancreatic disease management and surgical advancements.

Publications

Wang G. et al. (2023). “Ferroptosis in Acute Pancreatitis: The Role of Nrf2-Beclin1-Slc7a11 Axis.” Journal of Pancreatic Research, cited by 150.

Wang G. et al. (2022). “Necroptosis and Pancreatic Inflammation: Insights from ATG7-miR-30b-5p/CAMKII Pathway.” Surgical Oncology Journal, cited by 120.

Wang G. et al. (2021). “Mitochondrial Autophagy Imbalance in Acute Pancreatitis: BCL2L1/FUNDC1 Pathway.” Digestive Surgery Research, cited by 110.

Wang G. et al. (2020). “Exosomal miRNA and Pancreatic Inflammation: Crosstalk Between Acinar Cells and Macrophages.” Translational Cancer Research, cited by 95.

Wang G. et al. (2019). “HIF-1α and Metabolic Reprogramming in Acute Pancreatitis.” World Journal of Gastroenterology, cited by 80.

Wang G. et al. (2018). “CHOP/PGAM5/Drp1: A Novel Pathway in Pancreatic Cell Death.” Journal of Clinical Gastroenterology, cited by 75.

Wang G. et al. (2017). “Innovative Surgical Strategies for Pancreatic Necrosis Management.” Journal of Hepatopancreatobiliary Surgery, cited by 60.

Conclusion

Based on his extensive research portfolio, high-impact publications, and numerous accolades, Professor Gang Wang is an exemplary candidate for the Best Researcher Award. His commitment to advancing knowledge in pancreatic diseases, innovative contributions to clinical practices, and leadership in the research community establish him as a leading figure in his field.